Quercetin is a flavonol, a plant polyphenol found in capers, red onions, kale, apple skin and tea. In human trials it lowers blood pressure modestly at doses of 500 mg a day or more. Its wider reputation as an antioxidant, antihistamine and anti-ageing compound rests mostly on cell and animal work, held back by poor bioavailability.
Almost everything written about quercetin has the same structural problem. It lists effects observed on cells in a dish, or in rats, and presents them as things a capsule does to you. The gap between those two claims is the single most important fact about this molecule, and it has a name: bioavailability.
This article separates the two. What has been measured in humans, with the trial and the number. What has only been measured in vitro or in animals, and why that is not the same claim. And a third story that no British page covering quercetin mentions at all, which is where quercetin sits in serious ageing research.
What is quercetin, and where does it come from?
Quercetin is a flavonol, one branch of the flavonoid family, which is itself a branch of the polyphenols. It is not the branch it is most often confused with: the flavan-3-ols of cocoa and tea are a separate group with separate evidence, and one letter between the two names. Plants make it as a pigment and as part of their defence chemistry. Its close relative kaempferol sits on the same branch and travels with it in most foods, which is one reason food studies rarely isolate the effect of quercetin alone.
In plants it exists almost entirely bound to sugars, as glycosides. Quercetin glucoside from onion behaves quite differently from quercetin rutinoside from tea or apple, because the sugar attached determines where in the gut it is released and how much crosses into the blood. Supplements, by contrast, usually contain quercetin aglycone, the free form with no sugar, which is the least soluble version of all.
What food is highest in quercetin?
Capers, and it is not close. Dried capers contain several times the quercetin of any other common food by weight, though nobody eats them by weight. After capers the useful list is short and unglamorous.
- Red onions, with the outer layers far richer than the centre. Peeling generously throws away most of the quercetin in the onion.
- Kale and other brassicas, including broccoli.
- Apples with the skin on. The flesh contains very little. Peeling an apple removes most of its quercetin.
- Berries, particularly blueberries, cranberries and elderberries, and dark grapes.
- Tea, both green and black, and this matters disproportionately in Britain. Tea is one of the largest contributors to total flavonol intake in the UK diet, not because a cup is rich but because of how many are drunk.
- Capers, cherries, citrus peel and buckwheat, in descending order of how likely you are to eat them.
Typical dietary intake sits somewhere between 10 and 100 mg a day depending on how much fruit, veg and tea a person gets through. Hold that number, because it sets up the next section: supplement capsules contain 500 mg or 1 000 mg, five to a hundred times a day’s food intake. That distance between a compound on a plate and the same compound in a capsule is where most of the disappointing trials in this field come from.
The bioavailability problem nobody prints on the label
Quercetin has, in the words of the review by Yi Guo and Richard Bruno in the Journal of Nutritional Biochemistry in 2015, poor and highly variable bioavailability. Those two adjectives carry the whole argument. Poor, because only a fraction of what you swallow reaches the blood as quercetin. Variable, because how large that fraction is depends on the food form, the sugar attached, the fat eaten alongside it, and the individual’s gut bacteria.
What happens to quercetin between the plate and the plasma
Guo and Bruno make the consequence explicit: experimental findings on quercetin’s cardioprotective activity are inconsistent, and the cardioprotective effects routinely observed in vitro are not reliably reproduced in living people. The review calls for controlled trials examining dose-response and whether greater bioavailability actually produces greater benefit. That question was open in 2015 and it remains largely open.
This is also the reason formulations matter more here than in most supplement categories, and why quercetin is so often sold with bromelain, with vitamin C, or in phytosome and liposomal versions. Those are attempts to solve absorption. Some raise plasma levels. None has been shown to convert a higher plasma level into a better clinical outcome, which is the step that would matter.
Is quercetin an antihistamine?
Not in the sense that a pharmacy antihistamine is. Cetirizine and loratadine block the histamine H1 receptor, which is a specific, licensed, measurable action. Quercetin has been shown in laboratory work to stabilise mast cells, the immune cells that release histamine in the first place, and to inhibit the release rather than block the receptor.
That is a genuinely different mechanism, and on paper it is attractive: stop the histamine leaving the cell instead of blocking it once it has. The catch is where that evidence comes from. Most of the mast cell work is in vitro, using concentrations of quercetin that oral supplementation does not reliably reach in human plasma. Human trials in allergic rhinitis are small, short and heterogeneous.
For hay fever in Britain this has a practical shape. The NHS route is an antihistamine tablet or a steroid nasal spray, both available from a pharmacist without an appointment, both with licensed indications and known effect sizes. Quercetin is not a substitute for either, and it is not what a pharmacist will hand you. If you want to try it alongside, that is a conversation to have with the pharmacist rather than a swap to make quietly.
As for the most powerful natural antihistamine, the honest answer is that no natural compound has been shown to match a licensed H1 antagonist in a head-to-head trial. Quercetin, butterbur, stinging nettle and vitamin C all appear on lists of natural antihistamines, and butterbur has the most human data of the group. None of them has a licensed indication in the UK.
Blood pressure: the one outcome with a proper meta-analysis
Here the picture changes, because human randomised trials exist and someone has pooled them. Serban and colleagues published a systematic review and meta-analysis of placebo-controlled randomised controlled trials in the Journal of the American Heart Association in 2016, covering 7 trials with 9 treatment arms and 587 patients.
Quercetin reduced systolic blood pressure by a weighted mean of 3.04 mmHg, with a confidence interval of 5.75 to 0.33, and diastolic pressure by 2.63 mmHg, with a tighter interval of 3.26 to 2.01. Both were statistically significant.
Then the part that changes how you read a label. When the authors split the trials by dose, the effect was present only at 500 mg a day or more, where systolic pressure fell 4.45 mmHg and diastolic 2.98 mmHg. Below 500 mg a day there was no significant effect on either.
Blood pressure change with quercetin, by daily dose
Two things follow. A quercetin product dosed below 500 mg a day is below the level at which this outcome was seen at all. And a fall of 3 to 4 mmHg is real but modest: it is roughly what a meaningful reduction in salt intake achieves, and considerably less than a first-line blood pressure medicine. It is not a reason to change or stop a prescription.
Quercetin as a senolytic: the longevity story
This is the research strand that puts quercetin in ageing science rather than the vitamin aisle, and none of the pages currently ranking for quercetin in the UK mentions it.
As tissue ages it accumulates senescent cells: cells that have stopped dividing but refuse to die, and that secrete a mix of inflammatory signals known as the senescence-associated secretory phenotype. Senolytics are compounds that selectively kill those cells by disabling the survival pathways protecting them. Quercetin is one half of the best-studied senolytic combination, paired with dasatinib.
Two small human studies define what is actually known. Justice and colleagues ran a two-centre open-label pilot in 14 people with idiopathic pulmonary fibrosis, published in EBioMedicine in 2019, giving dasatinib 100 mg a day with quercetin 1 250 mg a day, three days a week for three weeks. Retention was 100%, one serious adverse event was reported, and other events were mostly mild to moderate.
Hickson and colleagues then published the first direct demonstration that senolytics reduce senescent cells in people, also in EBioMedicine in 2019. Nine participants with diabetic kidney disease, mean age 68.7 years, took dasatinib 100 mg and quercetin 1 000 mg for 3 days. Adipose tissue biopsied 11 days after the last dose showed a reduced burden of senescent cells.
DIETARY QUERCETIN
10 to 100 mg a day from onions, apples, kale and tea, alongside kaempferol and the rest of the plant. No isolated effect measurable.
SUPPLEMENT
500 to 1 000 mg a day. Modest blood pressure effect above 500 mg. Poor and variable absorption. No authorised health claim in Great Britain.
SENOLYTIC RESEARCH
Quercetin 1 000 to 1 250 mg WITH dasatinib, a prescription cancer drug, in trials of nine and fourteen people. Not a supplement protocol.
The caveat is the entire point. These are open-label studies with nine and fourteen participants and no control group, in people with serious disease. And the intervention is dasatinib plus quercetin. Dasatinib is a prescription tyrosine kinase inhibitor used in leukaemia, with a real side effect profile, and it is not available or appropriate as a longevity supplement. Nothing in these trials shows that quercetin alone clears senescent cells in a healthy person.
Antioxidant, anti-inflammatory and cancer: reading the laboratory work honestly
The volume of research on quercetin is enormous and most of it is preclinical. Its antioxidant properties are the starting point: the molecule donates electrons that neutralise free radicals, which is the basis of every claim made for it about oxidative stress, a state nobody can currently measure in you outside a research laboratory. Li and colleagues, in Nutrients in 2016, reviewed its anti-inflammatory and immune activity: it interferes with inflammatory signalling, reduces the production of inflammatory messengers, and modulates immune cell behaviour. Aghababaei and Hadidi, in Pharmaceuticals in 2023, surveyed the wider field of biological activities, including antioxidant, anti-inflammatory and anti-asthmatic effects.
Read the methods sections and a pattern appears. A great deal of this is cell culture and rats. That is not a criticism of the research, which is how mechanisms get worked out. It is a warning about what the conclusions support. A concentration that acts against an inflammatory pathway in cultured cells may be an order of magnitude above what circulates in a person taking a capsule, for the bioavailability reasons above.
The cancer literature deserves saying plainly. Quercetin affects proliferation and cell death pathways in tumour cell lines and in animal models, which is why it appears in thousands of papers. That is not evidence that it prevents or treats cancer in people, no clinical trial has shown that it does, and no such claim may be made about it in Great Britain. Anyone with a cancer diagnosis should raise any supplement with their oncology team before taking it, because interaction with treatment is a real concern rather than a theoretical one.
On claims generally: no health claim for quercetin appears on the Great Britain Nutrition and Health Claims Register, which since 1 January 2021 has been the only list a supplement sold in England, Scotland or Wales may draw health claims from. Northern Ireland continues to follow the EU list. That is why a British retailer’s quercetin page describes what the compound is and where it is found, and stops carefully short of saying what it will do for you.
Dose, side effects, and who should avoid quercetin
Supplements are typically sold at 500 mg or 1 000 mg a day, which is the range used in the trials that found a blood pressure effect. Doses above 1 000 mg a day are where reported side effects cluster, and they are mild: headache, tingling in the extremities, and stomach upset. Quercetin has a bitter taste, which is why powdered forms are unpopular.
Who should be careful, and this list is longer than most pages admit.
| Situation | Why it matters |
|---|---|
| Taking warfarin or another anticoagulant | Flavonoids have been reported to affect platelet function and drug metabolism. Ask your anticoagulation clinic. |
| Taking quinolone antibiotics | Quercetin has been reported to compete at the same bacterial target as ciprofloxacin and related antibiotics, and may reduce their effect. |
| Taking ciclosporin or other narrow-margin drugs | Quercetin inhibits CYP3A4 and P-glycoprotein in laboratory work, both of which control how much of many drugs reaches the blood. |
| On blood pressure medication | The effect is small but real. It adds to your medicine rather than replacing it, and it is worth mentioning at review. |
| Kidney disease | High doses over long periods have not been studied for renal safety, and the clearance route matters here. |
| Pregnant or breastfeeding | No adequate safety data at supplement doses. |
What happens when you start taking quercetin is, for most people, nothing perceptible. The measured outcomes are blood pressure and inflammatory markers, neither of which you feel. There is no reliable subjective signal that it is working, and anyone promising you one within a fortnight is describing something other than the trial evidence.
A closing note on where quercetin fits. If the reason you are reading this is joint stiffness or a persistent inflammatory background rather than blood pressure, quercetin is not the best-evidenced flavonoid for that job, and its absorption problem is exactly the one that a properly formulated bioavailable anti-inflammatory is designed to solve. The same logic drives support built for ageing joints: getting the active compound into the blood is most of the work. Neither is a treatment for a diagnosed condition, and persistent pain is a reason to see your GP.
Frequently asked questions
What is the main use of quercetin?
The best-evidenced use in humans is a modest reduction in blood pressure at doses of 500 mg a day or more. A meta-analysis of 7 randomised placebo-controlled trials in 587 patients found systolic pressure fell 3.04 mmHg on average, and 4.45 mmHg at the higher doses. Its other reputations, as an antioxidant and antihistamine, rest largely on cell and animal work.
Is quercetin an antihistamine?
Not in the way a pharmacy antihistamine is. Cetirizine and loratadine block the histamine H1 receptor. Quercetin has been shown in laboratory work to stabilise mast cells so they release less histamine in the first place. Most of that evidence is in vitro at concentrations oral supplements do not reliably reach, and human allergy trials are small.
What food is highest in quercetin?
Capers, by a wide margin, though few people eat them in quantity. In practice red onions are the most useful source, with the outer layers far richer than the centre, followed by kale and other brassicas, apples eaten with the skin on, berries, dark grapes and tea. Typical dietary intake is 10 to 100 mg a day.
Who should avoid taking quercetin?
Anyone pregnant or breastfeeding, where there is no adequate safety data. Anyone on warfarin or another anticoagulant, on ciclosporin or another narrow-margin medicine, or taking quinolone antibiotics such as ciprofloxacin, where interaction has been reported. Anyone with kidney disease or a cancer diagnosis should ask their clinical team first.
What happens when you start taking quercetin?
For most people, nothing they can feel. The outcomes measured in trials are blood pressure and inflammatory markers, neither of which produces a sensation. Side effects above 1 000 mg a day are reported as mild: headache, tingling in the hands or feet, and stomach upset. There is no reliable subjective sign that it is working.
What is the most powerful natural antihistamine?
No natural compound has been shown to match a licensed H1 antagonist in a head-to-head trial, and none has a licensed indication in the UK. Butterbur has the most human data among the candidates commonly listed, ahead of quercetin, stinging nettle and vitamin C. For hay fever the NHS route is an antihistamine tablet or a steroid nasal spray, both available from a pharmacist.
Is quercetin with bromelain better than quercetin alone?
Bromelain is added to address quercetin’s poor and highly variable absorption, and the same reasoning drives vitamin C, phytosome and liposomal versions. Some of these formats do raise plasma levels. None has been shown to turn a higher plasma level into a better clinical outcome, which is the step that would justify the price difference.
Sources
- Serban M.C., Sahebkar A., Zanchetti A., et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association, 2016. DOI: 10.1161/JAHA.115.002713
- Guo Y., Bruno R.S. Endogenous and exogenous mediators of quercetin bioavailability. The Journal of Nutritional Biochemistry, 2015. DOI: 10.1016/j.jnutbio.2014.10.008
- Hickson L.J., Langhi Prata L.G.P., Bobart S.A., et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine, 2019. DOI: 10.1016/j.ebiom.2019.08.069
- Justice J.N., Nambiar A.M., Tchkonia T., et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine, 2019. DOI: 10.1016/j.ebiom.2018.12.052
- Li Y., Yao J., Han C., et al. Quercetin, inflammation and immunity. Nutrients, 2016. DOI: 10.3390/nu8030167
- Aghababaei F., Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals, 2023. DOI: 10.3390/ph16071020
This article is general information, not medical advice. Food supplements do not replace a varied diet. If you take prescribed medicines, are pregnant or breastfeeding, have kidney disease or a cancer diagnosis, speak to your GP, your pharmacist or your clinical team before taking quercetin.
